Terra L. Lasho
Mayo Clinic(US)WinnMed(US)
Publications by Year
Research Areas
Myeloproliferative Neoplasms: Diagnosis and Treatment, Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments, Eosinophilic Disorders and Syndromes, Cancer Mechanisms and Therapy
Most-Cited Works
- → MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients(2006)1,032 cited
- → Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis(2014)716 cited
- → Circulating Interleukin (IL)-8, IL-2R, IL-12, and IL-15 Levels Are Independently Prognostic in Primary Myelofibrosis: A Comprehensive Cytokine Profiling Study(2011)583 cited
- → Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors(2009)568 cited
- → CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons(2014)536 cited
- → MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis(2017)521 cited
- → The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both “atypical” myeloproliferative disorders and myelodysplastic syndromes(2005)466 cited
- → TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis(2009)418 cited
- → MIPSS70+ Version 2.0: Mutation and Karyotype-Enhanced International Prognostic Scoring System for Primary Myelofibrosis(2018)369 cited
- → A Pilot Study of the Telomerase Inhibitor Imetelstat for Myelofibrosis(2015)317 cited